Annette Affolter

Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies

Steven R. Whittaker, Robert Hayward, Alfonso Zambon et al. · Science Translational Medicine · 2010 · 155 citations · Full text

Medicine, Cancer Biology, Oncology +17

<i>BRAF</i> and <i>NRAS</i> mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors

Udai Banerji, Annette Affolter, Ian Judson et al. · Molecular Cancer Therapeutics · 2008 · 70 citations · Full text

Medicine, Cancer Biology, Oncology +15

Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck

Julia Thierauf, J. Veit, Annette Affolter et al. · Melanoma Research · 2015 · 68 citations

Medicine, Oncology, Pathology +17

Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC

Chao Rong, Marie Müller, Fang Xiang et al. · British Journal of Cancer · 2020 · 50 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Comparison of p16^INK4a expression with p53 alterations in head and neck cancer by tissue microarray analysis

Syrus Karsai, Ulrich Abel, Mariana Roesch‐Ely et al. · The Journal of Pathology · 2006 · 45 citations

Medicine, Oncology, Pathology +15